Aurinia Pharm Ord (NQ: AUPH )
5.680
+0.080
(+1.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
All News about Aurinia Pharm Ord
![](https://mms.businesswire.com/media/20230104005890/en/1677187/22/aurina_logo.jpg)
What 4 Analyst Ratings Have To Say About Aurinia Pharmaceuticals
January 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/03/shutterstock_682967020.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230103005825/en/1676001/22/aurina_logo.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/biotech_bigpharma1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/01/03/image26.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230103005512/en/1675269/22/aurina_logo.jpg)
![](https://mms.businesswire.com/media/20221205005228/en/1654468/22/aurina_logo.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20221130005980/en/1651505/4/aurina_logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7002.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_29167.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
November 04, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_2022.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221103005471/en/1623981/4/aurina_logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/04/image29.jpeg?width=1200&height=800&fit=crop)
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
November 04, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/03/image24.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_5777.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221028005487/en/1618164/4/aurina_logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20221003005885/en/1590108/4/aurina_logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/24/image_4.jpg?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2022/08/09/image-karuna_therapeutics.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/04/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220804005355/en/1534764/4/aurina_logo.jpg)
![](https://mms.businesswire.com/media/20220801005741/en/1531009/4/aurina_logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13453.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.